You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
利民股份(002734.SZ)及子公司擬收購威遠資產組各10%股權
格隆匯 04-19 21:33

格隆匯4月19日丨利民股份(002734.SZ)公佈,公司及全資子公司蘇州利民生物科技有限責任公司(簡稱“蘇州利民”)擬使用自有或自籌資金合計1.73億元收購嘉興金榆新威股權投資合夥企業(有限合夥)(簡稱“新威投資”)持有的河北威遠生物化工有限公司(簡稱“威遠生化”)、河北威遠藥業有限公司(簡稱“威遠藥業”)及內蒙古新威遠生物化工有限公司(簡稱“新威遠”)(威遠生化、威遠藥業和新威遠以下合稱“威遠資產組”)各10%的股權,其中利民股份擬使用自有或自籌資金1.48億元收購新威投資持有的威遠生化及新威遠各10%的股權,蘇州利民擬使用自有或自籌資金2502萬元收購新威投資持有的威遠藥業10%的股權。

此次交易完成後,公司及全資子公司蘇州利民將合計持有威遠資產組100%股權,其中利民股份直接持有威遠生化96.71%、威遠藥業21.71%、新威遠96.71%的股權,通過蘇州利民持有威遠生化3.29%、威遠藥業78.29%、新威遠3.29%的股權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account